Clinical and electrophysiologic effects of chronic lorcainide therapy in refractory ventricular tachycardia
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 2 (3), 538-544
- https://doi.org/10.1016/s0735-1097(83)80282-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Rapid and simple method for determination of lorcainide, a new antiarrhythmic drug, and its major metabolite, norlorcainide, by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmiasAmerican Heart Journal, 1982
- Resistant Ventricular Arrhythmias Treated with Lorcainide, a New Antiarrhythmic DrugChest, 1980
- Electrophysiological Actions of Lorcainide in Patients with Cardiac DiseaseJournal of Cardiovascular Pharmacology, 1979
- Intracardiac electrophysiological effects of lorcainide in manEuropean Journal of Clinical Pharmacology, 1979
- Lorcainide infusion in the treatment of ventricular premature beats (VPB)European Journal of Clinical Pharmacology, 1979
- Initial clinical experience of lorcainide (Ro 13-1042), a new antiarrhythmic agentEuropean Journal of Clinical Pharmacology, 1978